by Eli Walsh
The COVID-19 vaccine targeting the original strain of the virus as well as two substrains of the omicron variant will now be used for all vaccinations in the U.S., federal regulators said Tuesday.
FDA: All COVID vaccinations to be bivalent vaccine to ‘simplify’ recommendations
